Elixinol Wellness (ASX:EXL) EBIT per Share: A$-0.02 (TTM As of Dec. 2025)


What is Elixinol Wellness EBIT per Share?

Elixinol Wellness ASX:EXL EBIT per Share is A$-0.02 as of Dec. 2025. The stock has 7 warning signs investors should review. Among 808 Drug Manufacturers companies, Elixinol Wellness ranks better than 88.86% on this metric.

Elixinol Wellness's EBIT per Share for the six months ended in Dec. 2025 was A$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 51.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 52.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Elixinol Wellness's EBIT per Share or its related term are showing as below:

ASX:EXL' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -88.7   Med: 51.1   Max: 54.1
Current: 51.1

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Elixinol Wellness was 54.10% per year. The lowest was -88.70% per year. And the median was 51.10% per year.

ASX:EXL's 3-Year EBIT Growth Rate is ranked better than
88.86% of 808 companies
in the Drug Manufacturers industry
Industry Median: 7.65 vs ASX:EXL: 51.10

Elixinol Wellness's EBIT for the six months ended in Dec. 2025 was A$-2.81 Mil.

Elixinol Wellness  (ASX:EXL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Elixinol Wellness EBIT per Share Related Terms

Elixinol Wellness EBIT per Share Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness EBIT per Share Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial -0.31 -0.20 -0.10 -0.03 -0.02

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.02 -0.01 -0.01 -0.01

Elixinol Wellness EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Elixinol Wellness's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-5.619/256.207
=-0.02

Elixinol Wellness's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.805/290.257
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of A$-0.02 mean?
Elixinol Wellness (ASX:EXL) has a EBIT per Share of A$-0.02 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Elixinol Wellness and its competitors. According to the industry distribution chart, Elixinol Wellness ranks #90 out of 808 companies in the Drug Manufacturers industry, placing it in the top 11.1%.
Is Elixinol Wellness' EBIT per Share too high?
Elixinol Wellness' current EBIT per Share is A$-0.02. Based on the distribution chart, Elixinol Wellness ranks #90 out of 808 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Elixinol Wellness' EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Elixinol Wellness ranks #90 out of 808 companies for EBIT per Share. This places Elixinol Wellness in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 7.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Elixinol Wellness and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixinol Wellness's current EBIT per Share is A$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current EBIT per Share is A$-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current EBIT per Share is A$-0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.